Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 3 Laboratory data before administration of cetuximab and just after loss of consciousness

From: Temporary loss of consciousness during cetuximab treatment of a patient with metastatic colon cancer: a case report

  Before administration Just after LOC
WBC (/μL) 4410 3400
RBC (×104/μL) 299 276
Hgb (g/dL) 9.6 8.6
PLT (×104/μL) 16.8 15.3
TP (g/dL) 5.3  
Alb (g/dL) 3.2  
T-Bil (mg/dL) 0.33  
AST (mU/mL) 31 27
ALT (mU/mL) 29 26
LDH (mU/mL) 252 229
ALP (mU/mL) 266 250
CRP (mg/dL) 0.16 0.13
Na (mmol/L) 143 141
K (mmol/L) 4.2 3.8
Cl (mmol/L) 111 113
Ca (mg/dL) 8.0 7.2
IP (mg/dL) 2.7 2.5
Mg (mg/dL) 0.9 2.8
BUN (mg/dL) 11 10.0
Cr (mg/dL) 1.00 0.81
eGFR (mL/min/1.73 m2) 56.6 71.3
  1. WBC white blood cell, RBC red blood cell, Hgb hemoglobin, PLT platelet, TP total protein, Alb albumin, T-Bil total bilirubin, AST aspartate aminotransferase, ALT alanine aminotransferase, LDH lactate dehydrogenase, ALP alkaline phosphatase, CRP C-reactive protein, Na sodium, K potassium, Cl chloride, Ca calcium, P phosphorus, Mg magnesium, BUN blood urea nitrogen, Cr creatinine, eGFR estimated glomerular filtration rate